Physician profile
Christopher Irobunda
NPI 1265516223
$718.03
in general payments reported to CMS, 2019-2025
10 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.17 · 2020: $119 · 2021: $60.67 · 2022: $311 · 2023: $47.19 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $257.46 | 2021-2022 | |
| Heartflow, INC. | $178.28 | 2022-2025 | |
| Bardy Diagnostics, INC. | $67.46 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $55.94 | 2022 | |
| Amgen INC. | $50.78 | 2019-2020 | |
| Kiniksa Pharmaceuticals, Ltd. | $26.12 | 2023 | Arcalyst |
| Daiichi Sankyo INC. | $24.26 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.00 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $21.07 | 2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $12.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Irobunda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.